PHK
NVCR icon

Point72 Hong Kong’s NovoCure NVCR Stock Holding History

Point72 Hong Kong’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$34.5K Sell
2,674
-8,947
-77% -$120K ﹤0.01% 390
2025
Q2 		$207K Buy
11,621
+7,609
+190% +$133K 0.01% 304
2025
Q1 		$71.5K Buy
+4,012
New +$91.1K ﹤0.01% 359
2024
Q4 		– Sell
-7,684
Closed -$120K – 550
2024
Q3 		$120K Sell
7,684
-10,940
-59% -$198K 0.01% 331
2024
Q2 		$319K Buy
18,624
+17,385
+1,403% +$306K 0.02% 276
2024
Q1 		$19.4K Buy
+1,239
New +$18.2K ﹤0.01% 483
2022
Q1 		– Sell
-4,825
Closed -$362K – 2185
2021
Q4 		$362K Buy
4,825
+3,699
+329% +$371K 0.01% 858
2021
Q3 		$131K Sell
1,126
-3,191
-74% -$482K ﹤0.01% 1274
2021
Q2 		$958K Buy
+4,317
New +$840K 0.03% 729
2020
Q4 		– Sell
-3,099
Closed -$345K – 1954
2020
Q3 		$345K Sell
3,099
-406
-12% -$32.5K 0.04% 357
2020
Q2 		$208K Buy
+3,505
New +$231K 0.02% 509
2019
Q4 		– Sell
-14
Closed -$1K – 1369
2019
Q3 		$1K Sell
14
-489
-97% -$39.1K ﹤0.01% 913
2019
Q2 		$32K Buy
503
+468
+1,337% +$23.7K 0.01% 699
2019
Q1 		$2K Buy
+35
New +$1.68K ﹤0.01% 898
2018
Q4 		– Sell
-563
Closed -$30K – 1110
2018
Q3 		$30K Buy
+563
New +$22.4K 0.01% 540

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Hong Kong's NVCR Position: Q3 2025 in Review

Point72 Hong Kong reduced its NovoCure (NVCR) stake by 77% in Q3 2025, selling an estimated $120K and leaving 2,674 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Point72 Hong Kong first reported a position in NVCR in Q3 2018 and has held it in 15 quarters since. The position peaked at $958K in Q2 2021. 245 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Point72 Hong Kong held 2,674 shares of NovoCure worth $34.5K as of Q3 2025.
  • Point72 Hong Kong sold 8,947 NovoCure shares in Q3 2025, an estimated $120K.
  • NovoCure made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #390 holding.
  • Point72 Hong Kong first reported a position in NovoCure in Q3 2018 and has held it in 15 quarters since.
  • Point72 Hong Kong's NovoCure position peaked at $958K in Q2 2021.
  • 245 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.